Combination of 4-anilinoquinazoline, arylurea and tertiary amine moiety to discover novel anticancer agents.

doi:10.1016/j.bmc.2015.12.001

Paper

Combination of 4-anilinoquinazoline, arylurea and tertiary amine moiety to discover novel anticancer agents.

Published Jan 15, 2016 · Sai-jie Zuo, Sai Zhang, Shuai Mao

Bioorganic & medicinal chemistry

Q2 SJR score

19

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

4-anilinoquinazoline derivatives bearing arylurea and tertiary amine moiety at their 6-position can serve as anticancer agents and EGFR inhibitors.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Combination of 4-anilinoquinazoline, arylurea and tertiary amine moiety to discover novel anticancer agents.

References

Citations